Are anti-ribosomal P protein antibodies a type of anti-lymphocyte antibody?, Clinical and Experimental Immunology, vol.109, issue.1, pp.1-3, 1997. ,
DOI : 10.1046/j.1365-2249.1997.00439.x
Autoantibodies specific for different isoforms of CD45 in systemic lupus erythematosus, Journal of Experimental Medicine, vol.172, issue.2, pp.653-659, 1990. ,
DOI : 10.1084/jem.172.2.653
Autoantibodies to CD45 in Systemic Lupus Erythematosus, Journal of Autoimmunity, vol.11, issue.5, pp.485-493, 1998. ,
DOI : 10.1006/jaut.1998.0225
Lupus IgG VH4.34 Antibodies Bind to a 220-kDa Glycoform of CD45/B220 on the Surface of Human B Lymphocytes, The Journal of Immunology, vol.172, issue.7, pp.4298-307, 2004. ,
DOI : 10.4049/jimmunol.172.7.4298
Autoantibody profiling to follow evolution of lupus syndromes, Arthritis Research & Therapy, vol.14, issue.4, 2012. ,
DOI : 10.1186/ar3927
Anti-ribosomal and 'P-peptide'-specific autoantibodies bind to T lymphocytes, Clinical and Experimental Immunology, vol.109, issue.1, pp.12-21, 1997. ,
DOI : 10.1046/j.1365-2249.1997.3691261.x
CD45 autoantibodies mediate neutralization of activated T cells from lupus patients through anergy or apoptosis, Lupus, vol.66, issue.8, pp.622-653, 2000. ,
DOI : 10.1016/0092-8674(91)90036-X
Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm, Journal of Clinical Investigation, vol.115, issue.4, pp.836-876, 2005. ,
DOI : 10.1172/JCI24791
Familial systemic lupus erythematosus: the role of genetic and environmental factors, Annals of the Rheumatic Diseases, vol.61, issue.1, pp.29-31, 2002. ,
DOI : 10.1136/ard.61.1.29